Center-Authored Papers

Filters: Author is Rendi, Mara H  [Clear All Filters]
F
Feng S, Weaver DL, Carney PA, Reisch LM, Geller BM, Goodwin A, Rendi MH, Onega T, Allison KH, Tosteson ANA et al..  2014.  A framework for evaluating diagnostic discordance in pathology discovered during research studies.. Archives of pathology & laboratory medicine. 138(7):955-61. Abstract
Flanagan MR, Rendi MH, Calhoun KE, Anderson BO, Javid SH.  2015.  Pleomorphic Lobular Carcinoma In Situ: Radiologic-Pathologic Features and Clinical Management.. Annals of surgical oncology. Abstract
Flanagan MR, Rendi MH, Gadi VK, Calhoun KE, Gow KW, Javid SH.  2015.  Adjuvant Endocrine Therapy in Patients with Ductal Carcinoma In Situ: A Population-Based Retrospective Analysis from 2005 to 2012 in the National Cancer Data Base.. Annals of surgical oncology. 22(10):3264-72. Abstract
L
Lehman CD, Lee JM, DeMartini WB, Hippe DS, Rendi MH, Kalish G, Porter P, Gralow J, Partridge SC.  2016.  Screening MRI in Women With a Personal History of Breast Cancer.. Journal of the National Cancer Institute. 108(3) Abstract
P
Parsian S, Giannakopoulos NV, Rahbar H, Rendi MH, Chai X, Partridge SC.  2016.  Diffusion-weighted imaging reflects variable cellularity and stromal density present in breast fibroadenomas.. Clinical imaging. 40(5):1047-1054. Abstract
R
Rahbar H, Parsian S, Lam DL, Dontchos BN, Andeen NK, Rendi MH, Lehman CD, Partridge SC.  2015.  Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ? Clinical imaging. Abstract